| Rituximab versus cyclophosphamide for ANCA-associated vasculitis JH Stone, PA Merkel, R Spiera, P Seo, CA Langford, GS Hoffman, ... New England Journal of Medicine 363 (3), 221-232, 2010 | 3032 | 2010 |
| Efficacy of remission-induction regimens for ANCA-associated vasculitis U Specks, PA Merkel, P Seo, R Spiera, CA Langford, GS Hoffman, ... New England Journal of Medicine 369 (5), 417-427, 2013 | 827 | 2013 |
| ANCA-associated vasculitis: core curriculum 2020 D Geetha, JA Jefferson American Journal of Kidney Diseases 75 (1), 124-137, 2020 | 357 | 2020 |
| Rituximab versus cyclophosphamide for ANCA-associated vasculitis with renal involvement D Geetha, U Specks, JH Stone, PA Merkel, P Seo, R Spiera, CA Langford, ... Journal of the American Society of Nephrology 26 (4), 976-985, 2015 | 181 | 2015 |
| Bladder carcinoma in a transplant recipient: evidence to implicate the BK human polyomavirus as a causal transforming agent D Geetha, BC Tong, L Racusen, JS Markowitz, WH Westra Transplantation 73 (12), 1933-1936, 2002 | 172 | 2002 |
| Pure red cell aplasia caused by Parvovirus B19 infection in solid organ transplant recipients: a case report and review of literature D Geetha, JB Zachary, HM Baldado, JD Kronz, ES Kraus Clinical transplantation 14 (6), 586-591, 2000 | 136 | 2000 |
| Clinical outcomes of remission induction therapy for severe antineutrophil cytoplasmic antibody–associated vasculitis EM Miloslavsky, U Specks, PA Merkel, P Seo, R Spiera, CA Langford, ... Arthritis & Rheumatism 65 (9), 2441-2449, 2013 | 132 | 2013 |
| Incidence and outcomes of BK virus allograft nephropathy among ABO-and HLA-incompatible kidney transplant recipients A Sharif, N Alachkar, S Bagnasco, D Geetha, G Gupta, K Womer, L Arend, ... Clinical journal of the American Society of Nephrology 7 (8), 1320-1327, 2012 | 122 | 2012 |
| Disease flare and reactogenicity in patients with rheumatic and musculoskeletal diseases following two‐dose SARS–CoV‐2 messenger RNA vaccination CM Connolly, JA Ruddy, BJ Boyarsky, I Barbur, WA Werbel, D Geetha, ... Arthritis & Rheumatology 74 (1), 28-32, 2022 | 114 | 2022 |
| Renal transplantation in antineutrophil cytoplasmic antibody-associated vasculitis: a multicenter experience D Geetha, A Eirin, K True, MV Irazabal, U Specks, P Seo, P Nachman, ... Transplantation 91 (12), 1370-1375, 2011 | 85 | 2011 |
| Contraceptive options for women with a history of solid-organ transplantation CM Krajewski, D Geetha, V Gomez-Lobo Transplantation 95 (10), 1183-1186, 2013 | 77 | 2013 |
| Rituximab for the treatment of relapses in antineutrophil cytoplasmic antibody–associated vasculitis EM Miloslavsky, U Specks, PA Merkel, P Seo, R Spiera, CA Langford, ... Arthritis & Rheumatology 66 (11), 3151-3159, 2014 | 75 | 2014 |
| Ureteral stents: a novel risk factor for polyomavirus nephropathy A Thomas, LK Dropulic, MH Rahman, D Geetha Transplantation 84 (3), 433-436, 2007 | 72 | 2007 |
| Results of repeat renal transplantation after graft loss from BK virus nephropathy D Geetha, SM Sozio, M Ghanta, M Josephson, R Shapiro, D Dadhania, ... Transplantation 92 (7), 781-786, 2011 | 66 | 2011 |
| Levamisole adulterated cocaine associated ANCA vasculitis: review of literature and update on pathogenesis Q Jin, S Kant, J Alhariri, D Geetha Journal of Community Hospital Internal Medicine Perspectives 8 (6), 339-344, 2018 | 60 | 2018 |
| Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab S Shah, Z Hruskova, M Segelmark, MD Morgan, J Hogan, SK Lee, J Dale, ... American journal of nephrology 41 (4-5), 296-301, 2015 | 56 | 2015 |
| Characteristics and outcome of crescentic glomerulonephritis in patients with both antineutrophil cytoplasmic antibody and anti-glomerular basement membrane antibody A Srivastava, GK Rao, PE Segal, M Shah, D Geetha Clinical rheumatology 32, 1317-1322, 2013 | 56 | 2013 |
| Validation of the new classification of pauci-immune glomerulonephritis in a United States cohort and its correlation with renal outcome CL Ellis, RL Manno, JP Havill, LC Racusen, D Geetha BMC nephrology 14, 1-7, 2013 | 55 | 2013 |
| Immunoglobulin levels and infection risk with rituximab induction for anti-neutrophil cytoplasmic antibody-associated vasculitis S Shah, K Jaggi, K Greenberg, D Geetha Clinical kidney journal 10 (4), 470-474, 2017 | 52 | 2017 |
| Rituximab for remission induction in elderly patients with ANCA-associated vasculitis H Timlin, SM Lee, RL Manno, P Seo, D Geetha Seminars in arthritis and rheumatism 45 (1), 67-69, 2015 | 52 | 2015 |
